DSM Acquires Chinese Resins Producer Syntech

Dutch specialty chemicals company Royal DSM N.V. has acquired Syntech, a producer and marketer of coating resins. Syntech has annual sales of around USD 30 million, generated with a broad portfolio of coating resins. The acquisition of Syntech further strengthens DSM's liquid coating resins portfolio and will enable DSM to further accelerate the expansion of its activities in the Chinese market.

The acquisition will be cash earnings per share enhancing as of year one.

The coating resins market in China is growing rapidly and Syntech has a leading position in the industry. Its flexible and modern production platform can be quickly adapted to expand production capacity. Syntech's activities are concentrated at one location in Shunde (Guangdong province). The site includes production facilities, self-owned R&D laboratories and a pilot plant for product development. The company's sales force is of a high quality and covers all relevant areas in China.

Peter Elverding, chairman of DSM's Managing Board of Directors, gave the following comment: "The acquisition of Syntech is the first step in the context of DSM's new strategy Vision 2010 - Building on Strengths. It serves two key strategic targets: growing our resins portfolio in the Performance Materials cluster and expanding our presence in the emerging China market. The acquisition provides an accelerated growth path into the Chinese coating resins market, from which our new and existing customers will benefit ."

DSM Coating Resins is rapidly growing its leading position in all coating resins markets. The acquisition of Syntech follows the takeover of NeoResins (now DSM NeoResins) in February of this year and will enable DSM to become one of the leading industrial coating resins suppliers in China.

http://www.dsm.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.